[#item_full_content] UK medical cannabis cultivator Glass Pharms has partnered with leading clinic Releaf to bring cannabis containing meaningful levels of THCV (Tetrahydrocannabivarin), a cannabinoid linked to reduced appetite in emerging research, to patients in the UK for the first time since 1973. Releaf has now secured Glass Pharms’ entire initial supply of 100kg, available to eligible
Read More